GHO CAPITAL
GHO Capital is a specialist healthcare investment advisor based in London. It applies global capabilities and perspectives to unlock high-growth healthcare opportunities in Europe, building market businesses of strategic global value.
GHO CAPITAL
Social Links:
Industry:
Financial Services Health Care
Founded:
2014-01-01
Status:
Active
Contact:
+44 20 3700 7440
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Font Awesome
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-11-15 | Genesis Research | Genesis Research acquired by GHO Capital | 275 M USD |
| 2021-08-04 | ClearView Healthcare Partners | ClearView Healthcare Partners acquired by GHO Capital | N/A |
| 2021-04-08 | Velocity Clinical Research | Velocity Clinical Research acquired by GHO Capital | N/A |
| 2020-11-05 | Envision Pharma Group | Envision Pharma Group acquired by GHO Capital | N/A |
| 2020-06-03 | X-Chem | X-Chem acquired by GHO Capital | N/A |
| 2020-01-09 | Ardena Group | Ardena Group acquired by GHO Capital | N/A |
| 2019-03-14 | Sterling Pharma Solutions | Sterling Pharma Solutions acquired by GHO Capital | N/A |
| 2018-12-20 | Validant | Validant acquired by GHO Capital | N/A |
| 2018-07-04 | Linimed | Linimed acquired by GHO Capital | N/A |
| 2018-05-01 | Alcaliber | Alcaliber acquired by GHO Capital | N/A |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-08-04 | Lykan BioScience | GHO Capital investment in Private Equity Round - Lykan BioScience | N/A |
| 2022-01-20 | RoslinCT | GHO Capital investment in Private Equity Round - RoslinCT | N/A |
| 2021-12-02 | Biocare Medical | GHO Capital investment in Private Equity Round - Biocare Medical | N/A |
| 2021-10-25 | Sanner Group | GHO Capital investment in Private Equity Round - Sanner Group | N/A |
| 2020-01-30 | Fairjourney Biologics | GHO Capital investment in Venture Round - Fairjourney Biologics | N/A |
| 2019-02-01 | BioAgilytix Labs | GHO Capital investment in Venture Round - BioAgilytix Labs | 23 M GBP |
Newest Events participated
More informations about "GHO Capital"
Avid Bioservices to be Acquired by GHO Capital Partners and …
Nov 7, 2024 Avid Bioservices, Inc. (NASDAQ: CDMO) (“Avid” or the “Company”), a dedicated biologics contract development and manufacturing organization (“CDMO”) working to improve …See details»
Sub Sector Focus - GHO Capital
With attractive business models combining high margins and low capital requirements, HealthTech represents a compelling investment opportunity. GHO is strategically positioned to …See details»
CDMOP - Avid Bioservices to be Acquired by GHO Capital...
TUSTIN, Calif. and LONDON and BOSTON, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO) (“Avid” or the “Company”), a dedicated biologics contract …See details»
GHO Capital Celebrates 10-Year Anniversary as Europe’s
3 days ago Further information: GHO Capital Partners LLP T +44 20 3700 7440 E [email protected] : For Media Enquiries ICR Healthcare Amber Fennell, Kris Lam Tel: +44 …See details»
Avid Bioservices to be Acquired by GHO Capital Partners and …
Nov 6, 2024 TUSTIN, Calif. and LONDON and BOSTON, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO) (“Avid” or the “Company”), a dedicated biologics …See details»
GHO Capital Celebrates 10-Year Anniversary as Europe’s Leading ...
3 days ago London, UK – 25 November 2024: Global Healthcare Opportunities, or GHO Capital Partners LLP (“GHO”), the European specialist investor in global healthcare, marks a decade …See details»
GHO Capital and The Vistria Group to acquire Alcami, a
Nov 8, 2022 Mike Mortimer and Alan MacKay, Managing Partners of GHO Capital, said: “We believe Alcami represents a unique opportunity to acquire a rapidly growing CDMO with …See details»
GHO Capital and The Vistria Group to acquire Alcami, a leading …
Nov 8, 2022 GHO Capital and The Vistria Group will acquire a 50/50 controlling interest in Alcami from funds affiliated with MDP and Ampersand. Ampersand and Alcami Management …See details»
GHO Capital and Partners Group invest in Sterling Pharma …
May 25, 2023 GHO Capital. GHO Capital and Partners Group invest in Sterling Pharma Solutions, a leading pharmaceutical development and manufacturing organization. Since first …See details»
Our Team - GHO Capital
GHO Capital Celebrates 10-Year Anniversary as Europe’s Leading Healthcare Private Equity Group + Read Update Avid Bioservices to be Acquired by GHO Capital Partners and Ampersand Capital Partners in $1.1 Billion TransactionSee details»
GHO Capital and Partners Group invest in Sterling Pharma
May 25, 2023 GHO Capital and Partners Group invest in Sterling Pharma Solutions, a leading pharmaceutical development and manufacturing organization. Since first partnering with GHO …See details»
GHO Capital and Partners Group invest in Sterling Pharma …
The Partners at GHO Capital commented: “We partner with management teams to deliver the healthcare of the future. Sterling is a leading example of how our deep industry expertise, …See details»
GHO Capital - Investments, Portfolio & Company Exits - Crunchbase
Nov 6, 2024 GHO Capital 's most notable exits include BioAgilytix Labs, Avid Biosciences, and RoslinCT. GHO Capital has acquired 16 organizations. Their most recent acquisition was …See details»
Specialist - GHO Capital
GHO Capital Celebrates 10-Year Anniversary as Europe’s Leading Healthcare Private Equity Group + Read Update Avid Bioservices to be Acquired by GHO Capital Partners and …See details»
GHO Capital and The Vistria Group Complete ... - Ampersand Capital
Jan 3, 2023 GHO Capital and The Vistria Group have acquired a 50/50 controlling interest in Alcami from funds affiliated with MDP and Ampersand. Ampersand and Alcami Management …See details»
GHO Capital and The Vistria Group Complete Acquisition of
North Carolina – January 3, 2023 – Global Healthcare Opportunities, or GHO Capital Partners LLP (“GHO”), and The Vistria Group today announced that they have completed the …See details»
GHO Capital Invests in RoslinCT, a Leading Cell Therapy CDMO
Jan 11, 2022 The Partners at GHO Capital said: “RoslinCT is renowned for its best-in-class services in developing and manufacturing advanced cell therapies and we are delighted to …See details»
GHO Capital Establishes Purpose Advisory Council to Support …
3 days ago Independent, cross-industry panel of leading advisors to support GHO Capital’s strategy, whilst maintaining the highest standards of Responsible Investing London, UK – 26 …See details»
Responsible Investing - GHO Capital
GHO is dedicated to encouraging a supportive, equitable and inclusive culture amongst the whole workforce and within our portfolio companies We recognise that diversity in background and …See details»
GHO Capital - Crunchbase Investor Profile & Investments
Nov 6, 2015 GHO Capital is a specialist healthcare investment advisor based in London. It applies global capabilities and perspectives to unlock high-growth healthcare opportunities in …See details»